← All trials
NCT04222985
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 30, 2020
- Primary completion
- Feb 28, 2023
- Completion date
- Feb 28, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 381
- Arms / groups
- 20 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Sanofi-AventisLead sponsor
- Sanofi-AventisStudy director
- Immune DesignCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.